Literature DB >> 16439126

Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.

Timothy Haemers1, Jochen Wiesner, Sara Van Poecke, Jan Goeman, Dajana Henschker, Edwald Beck, Hassan Jomaa, Serge Van Calenbergh.   

Abstract

In view of the promising antimalarial activity of fosmidomycin or its N-acetyl homologue FR900098, the objective of this work was to investigate the influence of aromatic substituents in the alpha-position of the phosphonate moiety. The envisaged analogues were prepared using a linear route involving a 3-aryl-3-phosphoryl propanal intermediate. The activities of all compounds were evaluated on Eschericia coli 1-deoxy-d-xylulose 5-phosphate reductoisomerase and against two Plasmodium falciparum strains. Compared with fosmidomycin, several analogues displayed enhanced activity towards the P. falciparum strains. Compound 1e with a 3,4-dichlorophenyl substitution in the alpha-position of fosmidomycin emerged as the most potent analogue of this series. It is approximately three times more potent in inhibiting the growth of P. falciparum than FR900098, the most potent representative of this class reported so far.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439126     DOI: 10.1016/j.bmcl.2005.12.082

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  A closer look at the spectroscopic properties of possible reaction intermediates in wild-type and mutant (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase.

Authors:  Weiya Xu; Nicholas S Lees; Dominique Hall; Dhanushi Welideniya; Brian M Hoffman; Evert C Duin
Journal:  Biochemistry       Date:  2012-06-07       Impact factor: 3.162

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor.

Authors:  Ryan E Cobb; Brian Bae; Zhi Li; Matthew A DeSieno; Satish K Nair; Huimin Zhao
Journal:  Chem Commun (Camb)       Date:  2015-02-14       Impact factor: 6.222

4.  MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.

Authors:  Xu Wang; Rachel L Edwards; Haley Ball; Claire Johnson; Amanda Haymond; Misgina Girma; Michelle Manikkam; Robert C Brothers; Kyle T McKay; Stacy D Arnett; Damon M Osbourn; Sophie Alvarez; Helena I Boshoff; Marvin J Meyers; Robin D Couch; Audrey R Odom John; Cynthia S Dowd
Journal:  J Med Chem       Date:  2018-09-24       Impact factor: 7.446

5.  Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies.

Authors:  Lisheng Deng; Jiasheng Diao; Pinhong Chen; Venugopal Pujari; Yuan Yao; Gang Cheng; Dean C Crick; B V Venkataram Prasad; Yongcheng Song
Journal:  J Med Chem       Date:  2011-06-02       Impact factor: 7.446

6.  Thermodynamic Investigation of Inhibitor Binding to 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase.

Authors:  Guobin Cai; Lisheng Deng; Bartlomiej G Fryszczyn; Nicholas G Brown; Zhen Liu; Hong Jiang; Timothy Palzkill; Yongcheng Song
Journal:  ACS Med Chem Lett       Date:  2012-05-07       Impact factor: 4.345

7.  Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics.

Authors:  Andrea Sass; Annelien Everaert; Heleen Van Acker; Freija Van den Driessche; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 8.  Biochemistry of the non-mevalonate isoprenoid pathway.

Authors:  Tobias Gräwert; Michael Groll; Felix Rohdich; Adelbert Bacher; Wolfgang Eisenreich
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

9.  Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase.

Authors:  Guobin Cai; Lisheng Deng; Jian Xue; Silvia N J Moreno; Boris Striepen; Yongcheng Song
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

10.  Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.

Authors:  Géraldine San Jose; Emily R Jackson; Amanda Haymond; Chinchu Johny; Rachel L Edwards; Xu Wang; R Carl Brothers; Emma K Edelstein; Audrey R Odom; Helena I Boshoff; Robin D Couch; Cynthia S Dowd
Journal:  ACS Infect Dis       Date:  2016-10-12       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.